Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma - focus on east and South-eastern Asia

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 5, 2010, Pages 1159-1166

  Shin, Hai Rim ^a,b   Oh, Jin Kyoung ^b   Masuyer, Eric ^a   Curado, Maria Paula ^a   Bouvard, Veronique ^a   Fang, Yueyi ^c   Wiangnon, Surapon ^d   Sripa, Banchob ^d   Hong, Sung Tae ^e  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b National Cancer Center   (South Korea)

^c Center for Disease Prevention and Control of Guangdong Province   (China)

^d KHON KAEN UNIVERSITY   (Thailand)

^e Seoul National University   (South Korea)

Author keywords

Coding practices; Extrahepatic cholangiocarcinoma; Incidence; International comparison; Intrahepatic cholangiocarcinoma

Indexed keywords

EID: 79955974642     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ben-Menachem T. (2007). Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol, 19, 615-7.
2. Blechacz BR, Gores GJ. (2008). Cholangiocarcinoma. Clin Liver Dis, 12, 131-50.
3. Bouvard V, Baan R, Straif K, et al. (2009). A review of human carcinogens-Part B: biological agents. Lancet Oncol, 10, 321-2.
4. Briggs CD, Neal CP, Mann CD, et al. (2009). Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer, 45, 33-47.
5. Catalano OA, Sahani DV, Forcione DG, et al. (2009). Biliary infections: spectrum of imaging findings and management. Radiographics, 29, 2059-80.
6. Chen MF. (1999). Peripheral cholangiocarcinoma. (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol, 14, 1144-9.
7. Chen MF, Jan YY, Jeng LB, et al. (1999). Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg, 6, 136-41.
8. Choi MS, Choi D, Choi MH, et al. (2005). Correlation between sonographic findings and infection intensity in clonorchiasis. Am J Trop Med Hyg, 73, 1139-44.
9. Dang TC, Yajima A, Nguyen VK, et al. (2008). Prevalence, intensity and risk factors for clonorchiasis and possible use of questionnaires to detect individuals at risk in northern Vietnam. Trans R Soc Trop Med Hyg, 102, 1263-8.
10. de Groen PC, Gores GJ, LaRusso NF, et al. (1999). Biliary tract cancers. N Engl J Med, 341, 1368-78.
11. DeOliveira ML, Cunningham SC, Cameron JL, et al. (2007). Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg, 245, 755-62.
12. Esposito I, Schirmacher P. (2008). Pathological aspects of cholangiocarcinoma. HPB. (Oxford), 10, 83-6.
13. Fraumeni JFJ. (1975). Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res, 35, 3437-46.
14. Fritz A, Percy C, Jack A, et al. (2000). International classification of diseases for oncology (ICD-O). 3rd ed. Geneva. (Switzerland): World Health Organization, 2000.
15. Gores GJ. (2003). Cholangiocarcinoma: current concepts and insights. Hepatology, 37, 961-9.
16. Hamilton SR, Aaltonen HL. (2000). World Health Organization classification of tumours: pathology and genetics of tumors of the digestive system. 3rd ed. Lyon: IARC Press, 2000.
17. Hsing AW, Gao YT, Devesa SS, et al. (1998). Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer, 75, 368-70.
18. Jepsen P, Vilstrup H, Tarone RE, et al. (2007). Incidence rates of intra-and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst, 99, 895-7.
19. Jung MY, Shin HR, Lee CU, et al. (1993). A study of the ratio of hepatocellular carcinoma over cholangiocarcinoma and their risk factors. J Pusan Medical Association, 29, 29-37.
20. Kato I, Kuroishi T, Tominaga S. (1990). Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol, 20, 232-7.
21. Khan SA, Davidson BR, Goldin R, et al. (2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut, 51, 1-9.
22. Khan SA, Taylor-Robinson SD, Toledano MB, et al. (2002). Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol, 37, 806-13.
23. Khan SA, Thomas HC, Davidson BR, et al. (2005). Cholangiocarcinoma. Lancet, 366, 1303-14.
24. Khan SA, Toledano MB, Taylor-Robinson SD. (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford), 10, 77-82.
25. Kim TS, Cho SH, Huh S, et al. (2009). A nationwide survey on the prevalence of intestinal parasitic infections in the Republic of Korea, 2004. Korean J Parasitol, 47, 37-47.
26. Kim YT, Byun JS, Kim J, et al. (2003). Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. Hepatogastroenterology, 50, 8-12.
27. Konishi M, Ochiai A, Ojima H, et al. (2008). A new histological classification for intra-operative histological examination of the ductal resection margin in cholangiocarcinoma. Cancer Sci.
28. Kubo S, Kinoshita H, Hirohashi K, et al. (1995). Hepatolithiasis associated with cholangiocarcinoma. World J Surg, 19, 637-41.
29. Lazaridis KN, Gores GJ,. (2005). Cholangiocarcinoma. Gastroenterology, 128, 1655-67.
30. LiverCancerStudyGroupofJapan. (1997). Intrahepatic cholangiocarcinoma, macroscopic typing. Tokyo (Japan): Kanehara.
31. Lun ZR, Gasser RB, Lai DH, et al. (2005). Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis, 5, 31-41.
32. Matull WR, Khan SA, Pereira SP. (2007). Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst, 99, 407-8.
33. McGlynn KA, Tarone RE, El-Serag HB. (2006). A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev, 15, 1198-203.
34. Nakamura Y, Leong ASY, Sripa B, et al. (2000) editors. Intrahepatic cholangiocarcinoma. Lyon (France): IARC, 2000.
35. Nakeeb A, Pitt HA, Sohn TA, et al. (1996). Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg, 224, 463-75.
36. Nathan H, Pawlik TM, Wolfgang CL, et al. (2007). Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg, 11, 1488-97.
37. Noauthorslisted. (1990). Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg, 211, 277-87.
38. Ohashi K, Tsutsumi M, Nakajima Y, et al. (1994). High rates of Ki-ras point mutation in both intra-and extra-hepatic cholangiocarcinomas. Jpn J Clin Oncol, 24, 305-10.
39. Okuda K, Nakanuma Y, Miyazaki M. (2002). Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol, 17, 1049-55.
40. Olnes MJ, Erlich R. (2004). A review and update on cholangiocarcinoma. Oncology, 66, 167-79.
41. Parkin DM, Ohshima H, Srivatanakul P, et al. (1993). Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev, 2, 537-44.
42. Patel T. (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33, 1353-7.
43. Patel T. (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 3, 10.
44. Percy C, Van Holten VandMuir C. (1990). International Classification of Diseases for Oncology (ICD-O). 2nd ed. Geneva. (Switzerland): World Health Organization.
45. Rashid A. (2002). Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am, 11, 995-1009.
46. Sasaki A, Aramaki M, Kawano K, et al. (1998). Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg, 85, 1206-9.
47. Shaib Y, El-Serag HB. (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, 115-25.
48. Shin HR, Oh JK, Masuyer E, et al. (2010). Epidemiology of cholangiocarcinoma: an update -focusing on risk factors-. Cancer Sci, 101, 579-85.
49. Sithithaworn P, Haswell-Elkins M. (2003). Epidemiology of Opisthorchis viverrini. Acta Trop, 88, 187-94.
50. Sripa B, Kaewkes S, Sithithaworn P, et al. (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, e201.
51. Sripa B, Pairojkul C. (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56.
52. Su CH, Shyr YM, Lui WY, et al. (1997). Hepatolithiasis associated with cholangiocarcinoma. Br J Surg, 84, 969-73.
53. Tominaga S, Kuroishi T. (1994). Biliary tract cancer. Cancer Surv, 19-20, 125-37.
54. Tominaga S, Kuroishi T, Ogawa H, et al. (1979). Epidemiologic aspects of biliary tract cancer in Japan. Natl Cancer Inst Monogr, 53, 25-34.
55. Tsuda H, Satarug S, Bhudhisawasdi V, et al. (1992). Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. Mol Carcinog, 6, 266-9.
56. Welzel TM, McGlynn KA, Hsing AW, et al. (2006). Impact of classification of hilar cholangiocarcinomas. (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst, 98, 873-5.
57. West J, Wood H, Logan RF, et al. (2006). Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer, 94, 1751-8.
58. Wood R, Brewster DH, Fraser LA, et al. (2003). Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer, 39, 2087-92.